Skip to content
10-K

Annual Report

PAR PHARMACEUTICAL COMPANIES, INC.

0000878088-15-000002

← back to feed
Filed
Mar 13, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Mar 12, 2015 100 sh
Long Term Debt FY 2014 · Dec 31, 2014 $1.9B
Long Term Debt FY 2014 · Dec 31, 2013 $1.52B
Short Term Debt FY 2014 · Dec 31, 2014 $14.5M
Short Term Debt FY 2014 · Dec 31, 2013 $21.46M
Cash And Equivalents FY 2014 · Dec 31, 2014 $244.44M
Cash And Equivalents FY 2014 · Dec 31, 2013 $130.08M
Stockholders Equity FY 2014 · Dec 31, 2014 $561.07M
Stockholders Equity restated FY 2014 · Dec 31, 2013 $548.06M
Current Liabilities FY 2014 · Dec 31, 2014 $277.8M
Current Liabilities FY 2014 · Dec 31, 2013 $258.97M
Current Assets FY 2014 · Dec 31, 2014 $653.05M
Current Assets FY 2014 · Dec 31, 2013 $465.58M
Total Assets FY 2014 · Dec 31, 2014 $3.01B
Total Assets restated FY 2014 · Dec 31, 2013 $2.64B